Medartis Holding AG Total Assets
Medartis Holding AG total assets. Based on the latest financial reports, Medartis Holding AG (MED) holds total assets worth CHF610.05 Million CHF (≈ $771.27 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Medartis Holding AG for the company's overall valuation and market capitalisation.
Total Assets of Medartis Holding AG (2014–2025)
Total assets of Medartis Holding AG from 2014 to 2025. This chart illustrates how Medartis Holding AG's total assets have evolved over time, based on quarterly financial data. See today's stock price for Medartis Holding AG for real-time trading data and today's change.
Medartis Holding AG - Asset Composition Analysis
Medartis Holding AG Total Assets Breakdown (December 2025)
Medartis Holding AG total assets breakdown as of December 2025. Medartis Holding AG's total assets of CHF610.05 Million consist of 34.9% current assets and 65.1% non-current assets.
| Asset Category | Amount (CHF) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF0.00 | 5.9% |
| Accounts Receivable | CHF60.91 Million | 10.9% |
| Inventory | CHF98.20 Million | 17.5% |
| Property, Plant & Equipment | CHF0.00 | 0.0% |
| Intangible Assets | CHF76.02 Million | 13.6% |
| Goodwill | CHF165.40 Million | 29.5% |
Asset Composition Trend (2014–2025)
This chart illustrates how Medartis Holding AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Medartis Holding AG short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medartis Holding AG's current assets represent 34.9% of total assets in 2025, a decrease from 39.5% in 2014.
- Cash Position: Cash and equivalents constituted 5.9% of total assets in 2025, up from 1.8% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 42.0% of total assets, an increase from 1.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 29.5% of total assets.
Medartis Holding AG Competitors by Total Assets
Key competitors of Medartis Holding AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Medartis Holding AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.36 | 5.31 | 5.62 |
| Quick Ratio | 1.72 | 3.57 | 3.83 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CHF147.04 Million | CHF214.88 Million | CHF142.50 Million |
Medartis Holding AG - Advanced Valuation Insights
This section examines the relationship between Medartis Holding AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.69 |
| Latest Market Cap to Assets Ratio | 1.85 |
| Asset Growth Rate (YoY) | 21.7% |
| Total Assets | CHF559.92 Million |
| Market Capitalization | $1.04 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Medartis Holding AG's assets above their book value (1.85x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Medartis Holding AG's assets grew by 21.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Medartis Holding AG (2014–2025)
The table below shows the annual total assets of Medartis Holding AG from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CHF559.92 Million ≈ $707.89 Million |
+21.73% |
| 2024-12-31 | CHF459.96 Million ≈ $581.52 Million |
+31.59% |
| 2023-12-31 | CHF349.53 Million ≈ $441.91 Million |
+6.60% |
| 2022-12-31 | CHF327.89 Million ≈ $414.55 Million |
+9.97% |
| 2021-12-31 | CHF298.18 Million ≈ $376.98 Million |
+5.44% |
| 2020-12-31 | CHF282.79 Million ≈ $357.53 Million |
-1.98% |
| 2019-12-31 | CHF288.51 Million ≈ $364.76 Million |
+12.79% |
| 2018-12-31 | CHF255.80 Million ≈ $323.41 Million |
+96.03% |
| 2017-12-31 | CHF130.49 Million ≈ $164.98 Million |
+13.23% |
| 2016-12-31 | CHF115.25 Million ≈ $145.70 Million |
+11.87% |
| 2015-12-31 | CHF103.02 Million ≈ $130.25 Million |
+5.10% |
| 2014-12-31 | CHF98.02 Million ≈ $123.92 Million |
-- |
About Medartis Holding AG
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, a… Read more